Imperial College London

DrCeciliaJohansson

Faculty of MedicineNational Heart & Lung Institute

Reader in Respiratory Immunology
 
 
 
//

Contact

 

+44 (0)20 7594 2531c.johansson

 
 
//

Location

 

367Wright Fleming WingSt Mary's Campus

//

Summary

 

Summary

Dr Cecilia Johansson is a Reader in Respiratory Immunology in the Section of Respiratory Infections, at the National Heart and Lung Institute, Imperial College London.

Dr Johansson did her undergraduate studies at UmeƄ University and Lund University, Sweden. She then did her PhD in the Section for Immunology at Lund University under the supervision of Professor Mary Jo Wick working on Salmonella infection and dendritic cells. She subsequently trained as a postdoctoral fellow with Brian Kelsall at the National Institutes of Health, Bethesda, USA, studying the role of type I interferons (IFNs) during intestinal virus infection.

In 2008, Cecilia set up an independent research group at Imperial College supported initially by a Career Development Award from the Medical Research Council. Her lab focuses on the generation and regulation of immunity via cellular crosstalk in the lung during viral infections. In particular, the lab studies the impact of type I interferons on lung inflammation and how these cytokines influence the induction of both innate and adaptive immune responses. In addition, her lab investigates how respiratory viral infections influence primary and metastatic lung cancer.

Cecilia is a member of the Medical Research Club, Faculty of 1000 and the Asthma UK Centre for Asthma and Allergy. She is also a member of the  Society for Mucosal Immunology Extramural Programs Committee and their membership committee. Cecilia also organises the Imperial CREST Academy through which Imperial College provides mentors for extracurricular science projects for 16-18 year old students. She is an associate editor for Mucosal Immunology and Frontiers in Immunology (Mucosal Immunology Section).

Selected Publications

Journal Articles

Johansson C, Makris S, 2020, R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice, Mucosal Immunology, ISSN:1933-0219

Kirsebom F, Michalaki C, Agueda-Oyarzabal M, et al., 2020, Neutrophils do not impact viral load or the peak of disease severity during RSV infection, Scientific Reports, Vol:10, ISSN:2045-2322

Nuriev R, Johansson C, 2019, Chemokine regulation of inflammation during respiratory syncytial virus infection., F1000res, Vol:8

Makris S, Paulsen M, Johansson C, 2017, Type I interferons as regulators of lung inflammation, Frontiers in Immunology, Vol:8, ISSN:1664-3224

Openshaw PJM, Chiu C, Culley FJ, et al., 2017, Protective and Harmful Immunity to RSV Infection, Annual Review of Immunology, Vol:35, ISSN:0732-0582, Pages:501-532

Johansson C, 2016, Respiratory syncytial virus infection: an innate perspective., F1000research, Vol:5, ISSN:2046-1402

Goritzka M, Makris S, Kausar F, et al., 2015, Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes, Journal of Experimental Medicine, Vol:212, ISSN:0022-1007, Pages:699-714

Goritzka M, Durant LR, Pereira C, et al., 2014, Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung during Respiratory Syncytial Virus Infection, Journal of Virology, Vol:88, ISSN:0022-538X, Pages:6128-6136

More Publications